Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blosozumab PK and Safety Study in Postmenopausal Women
NCT02109042Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2014
- Primary completion
- Jul 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of blosozumab in osteoporosis, sponsored by Eli Lilly and Company. Primary endpoints: Maximum Concentration of Blosozumab and Area Under the Concentration Curve of Blosozumab. Started Apr 2014; status: completed.
02
Drugs
blosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02109042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02109042.